Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UPXI.O
UPXI.O logo

UPXI.O Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.979
Open
0.940
VWAP
0.96
Vol
3.76M
Mkt Cap
68.01M
Low
0.910
Amount
3.59M
EV/EBITDA(TTM)
--
Total Shares
69.76M
EV
115.32M
EV/OCF(TTM)
--
P/S(TTM)
1.78
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
Show More

Events Timeline

(ET)
2026-04-02
08:50:00
Significant Increases in Indicative Borrow Rates for Liquid Options
select
2026-03-27 (ET)
2026-03-27
08:50:00
Rackspace Technology Borrow Rate Increases to 14.06%
select
2026-03-23 (ET)
2026-03-23
08:50:00
Rumble and Other Liquid Options See Borrow Rate Increases
select
2026-03-12 (ET)
2026-03-12
12:50:00
Brent Crude Soars Over 10% After Oil Tanker Attack in Iraq
select
2026-03-06 (ET)
2026-03-06
08:50:00
Laser Photonics Corporation Borrow Rate Increases to 92.43%
select
2026-02-06 (ET)
2026-02-06
08:40:00
Upexi Enters Agreement to Issue 6.337 Million Shares
select
2026-01-13 (ET)
2026-01-13
08:10:00
Upexi Enters $36M Convertible Note Agreement with Hivemind
select

News

NASDAQ.COM
2.0
02-11NASDAQ.COM
Upexi (UPXI) Q2 2026 Earnings Call Transcript
seekingalpha
9.5
02-11seekingalpha
Upexi, Inc. Q2 2026 Earnings Call Insights
  • Financial Performance Overview: Upexi reported total revenue of approximately $8.1 million for Q2, an increase of about $4 million year-over-year, despite a net loss of approximately $178.9 million primarily due to unrealized losses on digital assets and stock compensation expenses, indicating financial pressure amid market volatility.
  • Asset Management Strategy: CEO Allan Marshall emphasized that despite a 40% drop in Solana prices, the company plans to enhance its valuation by increasing Solana token holdings and yields, demonstrating a commitment to stability in uncertain markets.
  • Market Risk Mitigation: Management identified market volatility and declining Solana prices as key risks impacting quarterly results, with Marshall mentioning mergers and asset sales as potential mitigants, reflecting the company's adaptive strategies in the face of challenges.
  • Future Outlook: Although no specific earnings guidance was provided, management remains optimistic about Solana's long-term potential, planning to increase the number of tokens held in treasury and boost quarterly revenue from the treasury, indicating confidence in market recovery.
seekingalpha
9.5
02-10seekingalpha
Upexi Reports Q2 Loss Driven by Digital Asset Write-Downs
  • Quarterly Loss: Upexi reported a Q2 GAAP EPS of -$2.94, primarily driven by $164.5 million in unrealized losses on digital assets, reflecting significant non-cash fair value adjustments that adversely impacted the company's financial health.
  • Revenue Growth Pressure: Despite a 102.5% year-over-year revenue increase to $8.1 million, the figure fell short of expectations by $1.32 million, indicating competitive pressures in the market, particularly as revenue from the consumer brands segment totaled only $2.9 million.
  • Digital Asset Revenue: Revenue from digital assets, mainly from staking income, reached $5.1 million; however, this performance was insufficient to offset overall financial losses, highlighting the risks associated with the company's reliance on digital assets.
  • Financing Activities: Upexi entered into a $36 million convertible note deal backed by Solana with Hivemind Capital and plans to conduct a private placement offering of up to $23 million, aimed at enhancing liquidity and capital structure despite ongoing financial challenges.
moomoo
9.5
02-10moomoo
UPEXI Reports Q2 EPS of -$2.94
  • Market Overview: The U.S. stock market is experiencing fluctuations, with the S&P 500 index showing a slight decline of 2.94 points.
  • Economic Indicators: Recent economic data suggests mixed signals, impacting investor sentiment and market performance.
  • Sector Performance: Various sectors are reacting differently to economic news, with some showing resilience while others struggle.
  • Future Outlook: Analysts are closely monitoring upcoming economic reports that could influence market trends and investor decisions.
moomoo
9.5
02-10moomoo
UPEXI Reports Q2 Revenue of $8.1 Million
  • Company Overview: UPEXIQ reported a revenue of USD 8.1 million for the second quarter.
  • Financial Performance: The revenue reflects the company's growth and operational success during this period.
  • Market Position: UPEXIQ continues to strengthen its position in the market with increasing financial results.
  • Future Outlook: The company is optimistic about future performance and potential growth opportunities.
moomoo
9.5
02-10moomoo
UPEXI Reports Q2 Net Loss of USD 178.9 Million
  • Financial Performance: UPEX reported a net income of USD 178.9 million for the second quarter.
  • Comparison to Previous Period: This figure reflects a significant change compared to previous financial results, indicating growth or decline in profitability.
Wall Street analysts forecast UPXI.O stock price to rise
1 Analyst Rating
Wall Street analysts forecast UPXI.O stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Cantor Fitzgerald
Brett Knoblauch
Overweight
downgrade
$6 -> $2
AI Analysis
2026-02-11
Reason
Cantor Fitzgerald
Brett Knoblauch
Price Target
$6 -> $2
AI Analysis
2026-02-11
downgrade
Overweight
Reason
Cantor Fitzgerald analyst Brett Knoblauch lowered the firm's price target on Upexi to $2 from $6 and keeps an Overweight rating on the shares following the Q2 results. The firm continues to believe the Solana ecosystem is one of the most "vibrant" ecosystems across crypto, and while recent price performance paints a negative light on Solana, the core thesis that Solana can be the internet of capital markets remains true, the analyst tells investors in a research note.
Cantor Fitzgerald
Overweight -> NULL
downgrade
$16 -> $6
2025-11-14
Reason
Cantor Fitzgerald
Price Target
$16 -> $6
2025-11-14
downgrade
Overweight -> NULL
Reason
Cantor Fitzgerald lowered the firm's price target on Upexi to $6 from $16 and keeps an Overweight rating on the shares. With a large SOL treasury, discounted valuation, and new share repurchase authorization, the setup offers an appealing risk/reward profile, the analyst tells investors in a research note. The firm has removed the value applied to its treasury operations from its model.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UPXI.O
Unlock Now

Valuation Metrics

The current forward P/E ratio for Upexi Inc (Pre-Reincorporation) (UPXI.O) is 0.91, compared to its 5-year average forward P/E of -6.84. For a more detailed relative valuation and DCF analysis to assess Upexi Inc (Pre-Reincorporation)'s fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-6.84
Current PE
0.91
Overvalued PE
35.44
Undervalued PE
-49.12

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-214.24
Current EV/EBITDA
-0.38
Overvalued EV/EBITDA
928.60
Undervalued EV/EBITDA
-1357.08

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.82
Current PS
2.01
Overvalued PS
5.00
Undervalued PS
-1.37

Financials

AI Analysis
Annual
Quarterly

Whales Holding UPXI.O

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Upexi Inc (Pre-Reincorporation) (UPXI.O) stock price today?

The current price of UPXI.O is 0.9749 USD — it has decreased -1.32

What is Upexi Inc (Pre-Reincorporation) (UPXI.O)'s business?

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

What is the price predicton of UPXI.O Stock?

Wall Street analysts forecast UPXI.O stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI.O is6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Upexi Inc (Pre-Reincorporation) (UPXI.O)'s revenue for the last quarter?

Upexi Inc (Pre-Reincorporation) revenue for the last quarter amounts to 8.05M USD, increased 101.02

What is Upexi Inc (Pre-Reincorporation) (UPXI.O)'s earnings per share (EPS) for the last quarter?

Upexi Inc (Pre-Reincorporation). EPS for the last quarter amounts to -2.94 USD, increased 137.10

How many employees does Upexi Inc (Pre-Reincorporation) (UPXI.O). have?

Upexi Inc (Pre-Reincorporation) (UPXI.O) has 59 emplpoyees as of April 05 2026.

What is Upexi Inc (Pre-Reincorporation) (UPXI.O) market cap?

Today UPXI.O has the market capitalization of 68.01M USD.